Chronic obstructive pulmonary disease

Sanofi, Special care, Bill Sibold, chronic obstructive pulmonary disease

Sanofiā€™s specialty care chief Sibold leaves amid executive reshuffle

Anika Sharma

After an impressive six-year tenure steering Sanofi’s specialty care division, Bill Sibold is bidding adieu to embrace a new external ...

Verona Pharma has recently filed a New Drug Application to FDA for the use of ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease

Verona Pharma has recently filed a New Drug Application to FDA for the use of ensifentrine as a maintenance treatment for chronic obstructive pulmonary disease

SG Tylor

Source – Verona Pharma On June 27, 2023, Verona Pharma announced the submission of a New Drug Application (NDA) to ...